6 most recent filings and news items mentioning CODX. Updated every 60 seconds.
OfferingJul 31, 2026Neutral
Co-Diagnostics Inc. has entered into a placement agency agreement with Maxim Group LLC. Under this agreement, Maxim will act as the exclusive placement agent to sell Common Stock, Pre-Funded Warrants, and Common Warrants directly to investors as induced exercises of existing warr
View filing at SEC.gov →
NewsJul 30, 2026Neutral
Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine For a Rapidly Spreading Ebola Outbreak
View filing at SEC.gov →
BiotechJul 1, 2026Neutral
'White House Adds Pandemic Response Staff as Ebola Cases Rise' - Bloomberg News
View filing at SEC.gov →
BiotechJun 26, 2026Neutral
CDC Raises Its Response Level To Congo Ebola Outbreak To Level 1 Activation, Its Highest Level; Says Risk Of Ebola Spreading In The U.S. Remains Low
View filing at SEC.gov →
BiotechJun 5, 2026Neutral
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
View filing at SEC.gov →
OfferingMay 21, 2026Neutral
Co-Diagnostics issued pre-funded warrants exercisable for common stock starting May 21, 2026, under a securities purchase agreement dated May 19, 2026. The warrants were issued in an unregistered offering relying on exemptions from SEC registration requirements.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.